MSD Partners, L.P. - FINCH THERAPEUTICS GROUP INC ownership

FINCH THERAPEUTICS GROUP INC's ticker is FNCH and the CUSIP is 31773D101. A total of 54 filers reported holding FINCH THERAPEUTICS GROUP INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
MSD Partners, L.P. ownership history of FINCH THERAPEUTICS GROUP INC
ValueSharesWeighting
Q1 2023$60,285
-18.1%
153,3970.0%0.01%
-28.6%
Q4 2022$73,631
-88.7%
153,397
-60.5%
0.01%
-86.5%
Q3 2022$649,000
-41.2%
388,6910.0%0.05%
-23.5%
Q2 2022$1,104,000
-43.5%
388,6910.0%0.07%
-35.8%
Q1 2022$1,955,000
-83.2%
388,691
-66.7%
0.11%
-17.2%
Q4 2021$11,625,000
+130.1%
1,166,073
+200.0%
0.13%
-16.3%
Q3 2021$5,053,000
+52.6%
388,691
+65.2%
0.15%
+77.9%
Q2 2021$3,311,000
-47.3%
235,294
-39.5%
0.09%
-63.9%
Q1 2021$6,277,000388,6910.24%
Other shareholders
FINCH THERAPEUTICS GROUP INC shareholders Q1 2022
NameSharesValueWeighting ↓
Avenir Management Company, LLC 1,663,366$653,7033.23%
Bleichroeder LP 810,416$318,4930.07%
Ikarian Capital, LLC 237,553$93,3590.02%
LAKE STREET ADVISORS GROUP, LLC 739,136$2910.02%
Baupost Group 2,019,008$7930.01%
Proficio Capital Partners LLC 110,559$43,4500.01%
MSD Partners, L.P. 153,397$60,2850.01%
Ballentine Partners, LLC 143,603$56,4360.00%
SVB WEALTH LLC 253,054$99,4500.00%
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 18,783$7,3820.00%
View complete list of FINCH THERAPEUTICS GROUP INC shareholders